Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J3RB
|
||||
| Former ID |
DNC011299
|
||||
| Drug Name |
NSC-106080
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531262] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H16N2O2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)NNC(=C2C=CC=CC2=O)C3=CC=CC=C3O
|
||||
| InChI |
1S/C19H16N2O2/c22-17-12-6-4-10-15(17)19(16-11-5-7-13-18(16)23)21-20-14-8-2-1-3-9-14/h1-13,20-22H/b19-16+
|
||||
| InChIKey |
BUXNKWIOLSCTDX-KNTRCKAVSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NRH dehydrogenase [quinone] 2 | Target Info | Inhibitor | [531262] | |
| NAD(P)H dehydrogenase [quinone] 1 | Target Info | Inhibitor | [531262] | ||
| KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | ||||
| PathWhiz Pathway | Vitamin K Metabolism | ||||
| WikiPathways | Estrogen metabolism | ||||
| Oxidative Stress | |||||
| Transcriptional activation by NRF2 | |||||
| NRF2 pathway | |||||
| Nuclear Receptors Meta-Pathway | |||||
| Aryl Hydrocarbon Receptor Pathway | |||||
| Apoptosis-related network due to altered Notch3 in ovarian cancer | |||||
| Metabolism of amino acids and derivatives | |||||
| Aryl Hydrocarbon Receptor | |||||
| Dopamine metabolism | |||||
| Arylhydrocarbon receptor (AhR) signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.